Keynote comment: Reimbursement for molecularly targeted anticancer agents [1]

Umberto Tirelli, Gilberto de Castro, Ahmad Awada

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2-3
Number of pages2
JournalThe Lancet Oncology
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 2006

ASJC Scopus subject areas

  • Oncology

Cite this

Keynote comment : Reimbursement for molecularly targeted anticancer agents [1]. / Tirelli, Umberto; de Castro, Gilberto; Awada, Ahmad.

In: The Lancet Oncology, Vol. 7, No. 1, 01.2006, p. 2-3.

Research output: Contribution to journalArticle

Tirelli, Umberto ; de Castro, Gilberto ; Awada, Ahmad. / Keynote comment : Reimbursement for molecularly targeted anticancer agents [1]. In: The Lancet Oncology. 2006 ; Vol. 7, No. 1. pp. 2-3.
@article{de817bfddf004a5f8b23edee59de362d,
title = "Keynote comment: Reimbursement for molecularly targeted anticancer agents [1]",
author = "Umberto Tirelli and {de Castro}, Gilberto and Ahmad Awada",
year = "2006",
month = "1",
doi = "10.1016/S1470-2045(05)70512-X",
language = "English",
volume = "7",
pages = "2--3",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "1",

}

TY - JOUR

T1 - Keynote comment

T2 - Reimbursement for molecularly targeted anticancer agents [1]

AU - Tirelli, Umberto

AU - de Castro, Gilberto

AU - Awada, Ahmad

PY - 2006/1

Y1 - 2006/1

UR - http://www.scopus.com/inward/record.url?scp=29744462010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29744462010&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(05)70512-X

DO - 10.1016/S1470-2045(05)70512-X

M3 - Article

C2 - 16389172

AN - SCOPUS:29744462010

VL - 7

SP - 2

EP - 3

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 1

ER -